| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,200,356 ) |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK146149 | First person storytelling: Improving kidney education for Spanish speakers with advanced kidney disease | 000 | 1 | NIH | 1/26/2026 | $194,147 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 000 | 5 | NIH | 1/22/2026 | $414,060 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 3 | NIH | 1/28/2026 | $844,525 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 000 | 10 | NIH | 12/24/2025 | $435,369 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA061939 | Community-Engaged Development of a Peer Breastfeeding Support Intervention for Mothers with Opioid Use Disorder | 000 | 2 | NIH | 1/30/2026 | $193,619 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 003 | 5 | NIH | 2/11/2026 | $166,277 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34DA058124 | Sustaining recovery for people on opioid agonist treatment with conversational agents | 000 | 3 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 000 | 5 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA059908 | Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) Program | 000 | 1 | NIH | 1/8/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21CA286402 | Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors | 000 | 2 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA061933 | Promoting positive parenting for mothers with OUD: Implementation of a video-coaching intervention in pediatrics | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 000 | 3 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 001 | 5 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 5 | NIH | 1/8/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 002 | 5 | SAMHSA | 1/29/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 000 | 5 | SAMHSA | 1/14/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H1224845 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 02 | 13 | HRSA | 1/28/2026 | $0 |
| | 2026 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | 90ZT0224 | The Moving Forward Initiative for Survivors of Torture and Their Families | 01 | 4 | ACF | 2/3/2026 | $0 |
| | 2026 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL145126 | Improving Prehospital Pediatric Emergency Readiness with Telemedicine | 000 | 5 | NIH | 1/14/2026 | -$235 |
| | 2026 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 002 | 4 | NIH | 2/7/2026 | $0 |
| | 2026 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 001 | 4 | NIH | 2/6/2026 | $0 |
| | 2026 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 000 | 4 | NIH | 2/5/2026 | $0 |
| | 2026 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33AA027597 | Records for Alcohol Care Enhancement (RACE) | 000 | 5 | NIH | 1/14/2026 | -$33,972 |
| | 2026 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK126978 | Investigating the functional capacity of autoantibodies in primary membranous nephropathy | 000 | 3 | NIH | 1/7/2026 | $0 |
| | 2026 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI147316 | Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL) | 000 | 5 | NIH | 1/8/2026 | -$840 |
| | 2026 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL140133 | Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention | 002 | 4 | NIH | 1/14/2026 | -$12,594 |
| | 2026 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL140133 | Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention | 001 | 4 | NIH | 12/3/2025 | $84,115 |
| | 2026 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL140133 | Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention | 000 | 4 | NIH | 12/3/2025 | -$84,115 |
|
| Issue Date FY: 2025 ( Subtotal = $38,187,891 ) (Continued on the next page) |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01AI167733 | Nutritional Interventions to End Tuberculosis among persons with HIV in India (NUTRIENT-India) | 000 | 3 | NIH | 9/8/2025 | $128,403 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34DA058124 | Sustaining recovery for people on opioid agonist treatment with conversational agents | 000 | 3 | NIH | 8/22/2025 | $263,151 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 00 | 3 | CDC | 9/17/2025 | $461,000 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R56AI186777 | Mycobacterium tuberculosis disease effect on HIV-1 immunity, evolution, and persistence | 000 | 1 | NIH | 6/11/2025 | $711,993 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 001 | 4 | NIH | 7/17/2025 | $189,216 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DK136973 | Deep learning approach for the assessment of arterial and arteriolar lesions in kidney biopsies and prediction of cardiovascular risk | 000 | 2 | NIH | 8/19/2025 | $152,273 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 001 | 2 | NIH | 6/26/2025 | $79,606 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 2 | NIH | 4/22/2025 | $716,458 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166608 | Disease-specific risk factors for thrombosis following vascular interventions | 000 | 3 | NIH | 7/23/2025 | $678,195 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI172843 | Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission | 001 | 4 | NIH | 9/3/2025 | $1,407,828 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08AI166125 | Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection | 000 | 4 | NIH | 8/13/2025 | $193,752 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08DA058052 | Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder | 000 | 3 | NIH | 4/7/2025 | $186,527 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | D4054828 | Graduate Psychology Education Programs | 00 | 1 | HRSA | 6/11/2025 | $449,998 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA058367 | PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study | 000 | 3 | NIH | 6/18/2025 | $1,113,072 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 001 | 2 | NIH | 8/5/2025 | $0 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 001 | 2 | NIH | 8/5/2025 | $0 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 000 | 2 | NIH | 7/23/2025 | $175,212 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 000 | 2 | NIH | 7/23/2025 | $344,666 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 000 | 4 | NIH | 3/21/2025 | $372,536 |
|
